ACH vs INFU
ACH: Accendra Health delivers home healthcare equipment and medical supplies through Apria and Byram Healthcare brands, though the company faces severe financial headwinds including 75% revenue decline, negative profitability, and substantial debt relative to market value. INFU: InfuSystem is a specialized provider of durable medical equipment and managed healthcare services that enables the seamless transition of oncology and other infusion therapies from clinical settings to the home.
Side-by-side fundamentals
| Metric | ACH | INFU | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $3.16 | $8.90 | |
| Market cap as of 2026-07-23 | $255M | $185M | |
| P/E as of 2026-07-23 | n/a | 23.34 | |
| PEG as of 2026-07-23 | -0.00 | 0.16 | ACH lower |
| Net margin as of 2026-07-23 | -39.8% | +5.6% | INFU higher |
| Gross margin as of 2026-07-23 | +46.0% | +56.8% | INFU higher |
| Operating margin as of 2026-07-23 | +0.9% | +9.1% | INFU higher |
| ROE as of 2026-07-23 | -50.9% | +14.0% | INFU higher |
| ROA as of 2026-07-23 | -33.1% | +7.9% | INFU higher |
| Debt / equity as of 2026-07-23 | 3.41 | 0.33 | INFU lower |
| Revenue growth (YoY) as of 2026-07-23 | -74.7% | +3.5% | INFU higher |
| Revenue CAGR (3y) SEC XBRL | -34.8% | +9.3% | INFU higher |
| Dividend streak (yrs) SEC XBRL | 3 | n/a | |
| Beta as of 2026-07-23 | 1.59 | 1.49 | |
| 1-year return as of 2026-07-22 close | -55.8% | +66.1% | INFU higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.